Try our corporate solution for free!

AbbVie's R&D expenditures 2012-2021

AbbVie's research and development spending from 2012 to 2021

Loading statistic...
You need to log in to download this statistic
Register for free
Already a member?
Log in
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

2022

Region

Worldwide

Survey time period

2012 to 2021

Supplementary notes

* Research and development expenses in 2018 increased from 2017 principally due to a $5.1 billion intangible asset impairment charge related to IPR&D acquired as part of the 2016 Stemcentrx acquisition following the decision to stop enrollment in the TAHOE trial.

Statista Accounts: Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Starter Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access

Corporate solution including all features.

* Prices do not include sales tax.

Statistics on AbbVie

Market overview

6

Key figures

5

Business distribution

3

Competitors

5

Humira

5

Further related statistics

16
Statista Accounts: Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.